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Background:  Even with appropriate medical therapy, infants with paroxysmal supraventricular tachycardia (PSVT) have a risk of SVT recurrence 
after hospital discharge. SVT episodes may be hard to detect at home, and infants are at greater risk of prolonged SVT episodes than older children. 
Factors that increase the risk of recurrence are not known. The primary objectives were to 1) determine the rate of SVT recurrence after hospital 
discharge in the first year of life and 2) determine morbidity or mortality risk associated with SVT recurrence. The secondary objective was to 
determine factors predicting SVT recurrence. 
Methods:  Charts were reviewed for all infants <12 months of age with PSVT who were treated at the Children’s Hospital of Philadelphia from 2002 
to 2009. Atrial tachycardias and flutter were excluded and only infants with reentrant SVT were included. Data collected included age at diagnosis, 
length of hospital stay, antiarrhythmic medications used, and presence of congenital heart diseases (CHD), WPW, and/or prematurity. Recurrence 
was defined as any sustained ECG confirmed arrhythmia occurring on therapy after discharge and before age 1 year. 
Results:  Of 144 infants with PSVT, 35 (24%) had recurrence in the first year of life. Mean age at initial diagnosis was 23 days (median 10 days). 
16% were discharged on more than one drug. 32% had WPW. 10% had CHD. 24% were premature (< than 37 weeks gestation). 3 patients had 
shock from prolonged tachycardia during recurrence and all recovered fully. 5 patients died from non-arrhythmic events (4 with CHD and 1 with 
diaphragmatic hernia). Infants spending < 72 hours in the hospital after SVT diagnosis had significantly higher recurrence than those who were 
monitored for > 72 hrs (40% vs. 19%, p = 0.02). No other factor significantly predicted recurrence after discharge. 
Conclusions:  Though SVT recurrence after hospital discharge is not uncommon, it is associated with a low morbidity and low mortality in infants 
with structurally normal hearts. Infants with short hospital stays may have a higher risk of out-of-hospital recurrence and should be followed closely.
